Search research articles
Contact Us
Filters
Showing results (481-490 of 568) with videos related to
Page
of 57
Sort By:
British Journal of Cancer
|
January 1, 1983
Localisation and toxicity study of a vindesine-anti-CEA conjugate in patients with advanced cancer
C H Ford, C E Newman, J R Johnson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Cost-Utility of Cancer Therapies - the 'Cost' of Different Utility Generation Strategies
D M Meads, C McCabe, C T Hulme, et al.
Journal of Medicinal Chemistry
|
April 12, 1996
Lipophilic, acid-stable, adenosine deaminase-activated anti-HIV prodrugs for central nervous system delivery. 3. 6-Amino prodrugs of 2'-beta-fluoro-2',3'-dideoxyinosine
J S Driscoll, M A Siddiqui, H Ford, et al.
Journal of Medicinal Chemistry
|
March 1, 1996
4'-O-[2-(2-fluoromalonyl)]-L-tyrosine: a phosphotyrosyl mimic for the preparation of signal transduction inhibitory peptides
T R Burke, B Ye, M Akamatsu, et al.
The American Journal of Emergency Medicine
|
January 27, 2020
Heart rate variability measures for prediction of severity of illness and poor outcome in ED patients with sepsis
John E Arbo, Jeremy K Lessing, William J H Ford, et al.
AIDS Reviews
|
October 26, 2020
Efavirenz versus Protease Inhibitors in Patients with HIV: A Systematic Review and Meta-Analysis
Sabina O. Nduaguba, Chinyere Okoh, Jamie C. Barner, et al.
Journal of the American Chemical Society
|
May 22, 2025
Oxidized Overlayers of Ruthenium and Iridium as Electrocatalysts for Anodic Reactions
Conner J Soderstedt, Yong Yuan, S Avery Vigil, et al.
Clinical Drug Investigation
|
January 18, 2022
Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2-4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER)
Stewart J Tepper, Jessica Ailani, Janet H Ford, et al.
Clinical Drug Investigation
|
March 7, 2022
Correction to: Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2-4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER)
Stewart J Tepper, Jessica Ailani, Janet H Ford, et al.
Nurse Education Today
|
December 3, 2024
Promoting psychological safety in simulation using a novel visual tool: A mixed-methods quasi-experimental study
Jacqueline Vaughn, Shannon H Ford, Laura A Killam, et al.
Page
of 57
Search research articles
Search
Showing results (481-490 of 568) with videos related to
Sort By:
Page
of 57
British Journal of Cancer
|
January 1, 1983
Localisation and toxicity study of a vindesine-anti-CEA conjugate in patients with advanced cancer
C H Ford, C E Newman, J R Johnson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Cost-Utility of Cancer Therapies - the 'Cost' of Different Utility Generation Strategies
D M Meads, C McCabe, C T Hulme, et al.
Journal of Medicinal Chemistry
|
April 12, 1996
Lipophilic, acid-stable, adenosine deaminase-activated anti-HIV prodrugs for central nervous system delivery. 3. 6-Amino prodrugs of 2'-beta-fluoro-2',3'-dideoxyinosine
J S Driscoll, M A Siddiqui, H Ford, et al.
Journal of Medicinal Chemistry
|
March 1, 1996
4'-O-[2-(2-fluoromalonyl)]-L-tyrosine: a phosphotyrosyl mimic for the preparation of signal transduction inhibitory peptides
T R Burke, B Ye, M Akamatsu, et al.
The American Journal of Emergency Medicine
|
January 27, 2020
Heart rate variability measures for prediction of severity of illness and poor outcome in ED patients with sepsis
John E Arbo, Jeremy K Lessing, William J H Ford, et al.
AIDS Reviews
|
October 26, 2020
Efavirenz versus Protease Inhibitors in Patients with HIV: A Systematic Review and Meta-Analysis
Sabina O. Nduaguba, Chinyere Okoh, Jamie C. Barner, et al.
Journal of the American Chemical Society
|
May 22, 2025
Oxidized Overlayers of Ruthenium and Iridium as Electrocatalysts for Anodic Reactions
Conner J Soderstedt, Yong Yuan, S Avery Vigil, et al.
Clinical Drug Investigation
|
January 18, 2022
Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2-4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER)
Stewart J Tepper, Jessica Ailani, Janet H Ford, et al.
Clinical Drug Investigation
|
March 7, 2022
Correction to: Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2-4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER)
Stewart J Tepper, Jessica Ailani, Janet H Ford, et al.
Nurse Education Today
|
December 3, 2024
Promoting psychological safety in simulation using a novel visual tool: A mixed-methods quasi-experimental study
Jacqueline Vaughn, Shannon H Ford, Laura A Killam, et al.
Page
of 57